 
PDB ID
|
Resolution
|
Source
|
Class
|
Ligands
|
Binding Data
|
Molecular Weight (Da)
|
|---|---|---|---|---|---|---|
| 1T3R | 1.2 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, PO4) | Ki = 14 pM | 547.664 |
| 1T7I | 1.35 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACT, PO4) | 547.664 | |
| 2F80 | 1.45 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, SO4) | Ki = 6.6 nM | 547.664 |
| 2F81 | 1.25 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, GOL, NA) | Ki = 0.03 nM | 547.664 |
| 2F8G | 1.22 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACY, CL, GOL, NA) | Ki = 2 nM | 547.664 |
| 2HS1 | 0.84 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, DMS) | Ki = 3.3 nM | 547.664 |
| 2HS2 | 1.22 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, DMS) | Ki = 4.9 nM | 547.664 |
| 2IDW | 1.1 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACY, CL, DMS, GOL, PO4) | Ki = 1.3 nM | 547.664 |
| 2IEN | 1.3 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACY, CL, GOL, NA) | Ki = 1 nM | 547.664 |
| 2IEO | 1.53 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, NA) | Ki = 3.2 nM | 547.664 |
| 3BVB | 1.3 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL, GOL, NA) | Ka = 3170000 M^-1 | 547.664 |
| 3CYW | 1.4 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | ENZYME 3.4.23.16 | 017 (017, CL, GOL) | Ki = 17 nM | 547.664 |
| 3D1Z | 1.3 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | ENZYME 3.4.23.16 | 017 (017, ACY, CL) | Ki = 1.6 nM | 547.664 |
| 3D20 | 1.05 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | ENZYME 3.4.23.16 | 017 (017, CL, NA) | Ki = 5 nM | 547.664 |
| 3EBZ | 1.2 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 (IROD) | ENZYME 3.4.23.16 | 017 (017, CL, IMD, NA, ZN) | 547.664 | |
| 3EKT | 1.97 | HIV-1 M:B_ARV2/SF2 | ENZYME 3.4.23.16 | 017 (017, ACT, PO4) | Kd = 0.026 nM | 547.664 |
| 3GGU | 1.8 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BISOLATE) | ENZYME 3.4.23.16 | 017 (017) | Ki = 170 pM | 547.664 |
| 3JVY | 1.6 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BISOLATE) | ENZYME 3.4.23.16 | 017 (017, CL, NA) | 547.664 | |
| 3JW2 | 1.8 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BISOLATE) | ENZYME 3.4.23.16 | 017 (017, CL, NA) | 547.664 | |
| 3LZS | 1.95 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACT) | Kd = 0.0109 nM | 547.664 |
| 3LZU | 1.76 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACT) | Kd = 0.087 nM | 547.664 |
| 3LZV | 2.15 | HIV-1 M:B_ARV2/SF2 | ENZYME 3.4.23.16 | 017 (017, ACT, PO4) | Kd = 0.026 nM | 547.664 |
| 3MWS | 1.09 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, CL) | 547.664 | |
| 3OGP | 1.7 | FELINE IMMUNODEFICIENCY VIRUS | ENZYME 3.4.23.16 | 017 (017, DMS) | ic50 = 36 nM | 547.664 |
| 3PWM | 1.46 | HUMAN IMMUNODEFICIENCY VIRUS 1 | ENZYME 3.4.23.16 | 017 (017, ACT, CL, NA) | 547.664 |
